|
1
|
Seftor EA, Meltzer PS, Kirschmann DA,
Pe’er J, Maniotis AJ, Trent JM, Folberg R and Hendrix MJ: Molecular
determinants of human uveal melanoma invasion and metastasis. Clin
Exp Metastasis. 19:233–246. 2002.
|
|
2
|
Triozzi PL, Eng C and Singh AD: Targeted
therapy for uveal melanoma. Cancer Treat Rev. 34:247–258. 2008.
|
|
3
|
Singh AD, Turell ME and Topham AK: Uveal
melanoma: trends in incidence, treatment, and survival.
Ophthalmology. 118:1881–1885. 2011.
|
|
4
|
Sun Q, Cong R, Yan H, Gu H, Zeng Y, Liu N,
Chen J and Wang B: Genistein inhibits growth of human uveal
melanoma cells and affects microRNA-27a and target gene expression.
Oncol Rep. 22:563–567. 2009.
|
|
5
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009.
|
|
6
|
Tsai KW, Liao YL, Wu CW, Hu LY, Li SC,
Chan WC, et al: Aberrant hypermethylation of miR-9 genes in gastric
cancer. Epigenetics. 6:1189–1197. 2011.
|
|
7
|
Wan HY, Guo LM, Liu T, Liu M, Li X and
Tang H: Regulation of the transcription factor NF-kappaB1 by
microRNA-9 in human gastric adenocarcinoma. Mol Cancer.
9:162010.
|
|
8
|
Hu X, Schwarz JK, Lewis JS, Huettner PC,
Rader JS, Deasy JO, et al: A microRNA expression signature for
cervical cancer prognosis. Cancer Res. 70:1441–1448. 2010.
|
|
9
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, et al: miR-9, a MYC/MYCN-activated microRNA, regulates
E-cadherin and cancer metastasis. Nat Cell Biol. 12:247–256.
2010.
|
|
10
|
Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng
S and Ge W: MicroRNA-9 up-regulation is involved in colorectal
cancer metastasis via promoting cell motility. Med Oncol.
29:1037–1043. 2012.
|
|
11
|
Liu S, Kumar SM, Lu H, Liu A, Yang R,
Pushparajan A, Guo W and Xu X: MicroRNA-9 up-regulates E-cadherin
through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol.
226:61–72. 2012.
|
|
12
|
Amiri KI and Richmond A: Role of nuclear
factor-kappa B in melanoma. Cancer Metastasis Rev. 24:301–313.
2005.
|
|
13
|
Pereira SG and Oakley F: Nuclear
factor-kappaB1: regulation and function. Int J Biochem Cell Biol.
40:1425–1430. 2008.
|
|
14
|
Vaisanen A, Kallioinen M, von Dickhoff K,
Laatikainen L, Hoyhtya M and Turpeenniemi-Hujanen T: Matrix
metalloproteinase-2 (MMP-2) immunoreactive protein - a new
prognostic marker in uveal melanoma? J Pathol. 188:56–62. 1999.
|
|
15
|
Sahin A, Kiratli H, Soylemezoglu F, Tezel
GG, Bilgic S and Saracbasi O: Expression of vascular endothelial
growth factor-A, matrix metalloproteinase-9, and extravascular
matrix patterns and their correlations with clinicopathologic
parameters in posterior uveal melanomas. Jpn J Ophthalmol.
51:325–331. 2007.
|
|
16
|
Hendrix MJ, Seftor EA, Meltzer PS, Gardner
LM, Hess AR, et al: Expression and functional significance of
VE-cadherin in aggressive human melanoma cells: role in
vasculogenic mimicry. Proc Natl Acad Sci USA. 98:8018–8023.
2001.
|
|
17
|
Dror R, Lederman M, Umezawa K, Barak V,
Pe’er J and Chowers I: Characterizing the involvement of the
nuclear factor-kappa B (NF kappa B) transcription factor in uveal
melanoma. Invest Ophthalmol Vis Sci. 51:1811–1816. 2010.
|
|
18
|
Yan C and Boyd DD: Regulation of matrix
metalloproteinase gene expression. J Cell Physiol. 211:19–26.
2007.
|
|
19
|
Karst AM, Gao K, Nelson CC and Li G:
Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis
by upregulating interleukin-6 expression. Int J Cancer.
124:494–501. 2009.
|
|
20
|
Yang C and Wei W: The miRNA expression
profile of the uveal melanoma. Sci China Life Sci. 54:351–358.
2011.
|
|
21
|
Yan D, Zhou X, Chen X, Hu DN, Dong XD,
Wang J, et al: MicroRNA-34a inhibits uveal melanoma cell
proliferation and migration through downregulation of c-Met. Invest
Ophthalmol Vis Sci. 50:1559–1565. 2009.
|
|
22
|
Worley LA, Long MD, Onken MD and Harbour
JW: Micro-RNAs associated with metastasis in uveal melanoma
identified by multiplexed microarray profiling. Melanoma Res.
18:184–190. 2008.
|
|
23
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, et al: Epigenetic regulation of microRNA
expression in colorectal cancer. Int J Cancer. 125:2737–2743.
2009.
|
|
24
|
Omura N, Li CP, Li A, Hong SM, Walter K,
Jimeno A, et al: Genome-wide profiling of methylated promoters in
pancreatic adenocarcinoma. Cancer Biol Ther. 7:1146–1156. 2008.
|
|
25
|
Ferretti E, De Smaele E, Po A, Di
Marcotullio L, Tosi E, Espinola MS, et al: MicroRNA profiling in
human medulloblastoma. Int J Cancer. 124:568–577. 2009.
|
|
26
|
Laios A, O’Toole S, Flavin R, Martin C,
Kelly L, Ring M, et al: Potential role of miR-9 and miR-223 in
recurrent ovarian cancer. Mol Cancer. 7:352008.
|
|
27
|
Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W,
Tamboli P, et al: Hsa-miR-9 methylation status is associated with
cancer development and metastatic recurrence in patients with clear
cell renal cell carcinoma. Oncogene. 29:5724–5728. 2010.
|
|
28
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, et al: Definition of microRNAs that repress
expression of the tumor suppressor gene FOXO1 in endometrial
cancer. Cancer Res. 70:367–377. 2010.
|
|
29
|
Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo
T and Yuasa Y: MiR-9 downregulates CDX2 expression in gastric
cancer cells. Int J Cancer. 129:2611–2620. 2011.
|
|
30
|
Wöll E, Bedikian A and Legha SS: Uveal
melanoma: natural history and treatment options for metastatic
disease. Melanoma Res. 9:575–581. 1999.
|
|
31
|
Gao K, Dai DL, Martinka M and Li G:
Prognostic significance of nuclear factor-kappaB p105/p50 in human
melanoma and its role in cell migration. Cancer Res. 66:8382–8388.
2006.
|
|
32
|
El-Shabrawi Y, Ardjomand N and Radner H:
MMP-9 is predominantly expressed in epithelioid and not spindle
cell uveal melanoma. J Pathol. 194:201–206. 2001.
|
|
33
|
Crosby MB, Yang H, Gao W, Zhang L and
Grossniklaus HE: Serum vascular endothelial growth factor (VEGF)
levels correlate with number and location of micrometastases in a
murine model of uveal melanoma. Br J Ophthalmol. 95:112–117.
2011.
|
